Decline depth
-22.1%
From rolling 252-day high of $28.35, 142d ago.
Past the 20% Watch threshold.
-22.1%
from rolling 252-day high of $28.35 set 2025-12-23 · 142d ago
Current
$22.09
Decline depth
-22.1%
Decline σ
2.3σ
TFC
2/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
ACAD qualifies for the Watch on decline depth.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
2.3σ
Drop from local high over the last 10 bars, expressed in units of the stock's typical daily volatility (2.23% per day).
The structural read
What price action says about ACAD.
ACAD qualifies for the Watch on decline depth — down -22.1% from its rolling 252-day high.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2U (red), weekly 1 (red), monthly 2U (red).
Earnings on file: 2026-02-25. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $13.40
58.1% of range
52W high $28.35
Sector context · Healthcare
182 other Healthcare tickers are on Broken Stocks.
93
Red List
43
Amber
46
Watch
-35.8%
Median decline
Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →
Related — same sector
Closest decliners to ACAD
Red List
STOK
Stoke Therapeutics, Inc.
Watch Recovering
BIOA
BioAge Labs, Inc.
Watch Recovering
KURA
Kura Oncology, Inc.
Amber List
INFU
InfuSystems Holdings, Inc.
Watch
SHC
Sotera Health Company
Watch
ELAN
Elanco Animal Health Incorporat
Questions about ACAD
What people ask.
Why is ACAD on Broken Stocks?
ACAD qualifies for the Watch on decline depth. It is down -22.1% from its rolling 252-day high of $28.35, set on 2025-12-23 — 142d ago.
Is ACAD a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. ACAD is down -22.1% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is ACAD a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is ACAD trading inside its 52-week range?
At $22.09, ACAD sits 58.1% of the way from its 52-week low ($13.40) to its 52-week high ($28.35). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has ACAD been declining?
The current 22.1% decline accrued over 142d, which annualizes to roughly -56.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does ACAD compare to its sector?
There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 43 Amber, 46 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — ACAD's decline is shallower than the sector median.
Does ACAD's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-02-25) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.